Skip to main content

Table 3 Characteristics of patients with treatment failure

From: Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer

Sex

Age

Initial CEA

pT

Excision

Margin

Radiation dose

Disease-free interval (Months)

Failure site

Salvage treatment

Months after recurrence

Last status

Female

69

2.11

2

TAE

1.2 mm

50.4 Gy

18

Lt. perirectal area (IFF)

Laparoscopic mass excision + CCRT

30

Alive with disease

Female

76

2.24

2

TAE

unknown

50.4 Gy

37

rectum (IFF)

Laparoscopic APR+ 5-FU

57

Alive without disease

Male

69

4.75

1

EMR

1 mm

50.4 Gy

19

rectum (IFF), liver, lung

Capecitabine

32

Alive with disease

Male

68

2.04

2

TAE

0 mm

50.4 Gy

16

liver

liver S6 segmentectomy

87

Alive without disease

Male

67

unknown

1

TAE

unknown

48.6 Gy

23

liver

No

9

Dead with disease

  1. CEA carcinoembryonic antigen, pT pathologic T-stage, TAE transanal excision, IFF in-field failure, CCRT concurrent chemoradiotherapy, APR abdominoperineal resection, 5-FU 5-fluorouracil, EMR endoscopic mucosal resection